WHO updates laboratory biosecurity guidance at AshTip Solution.

It's tough to keep up with the proliferation of monoclonal antibodies. Seems every day I'm confronted by a patient who's using a new drug with a name ending in "mab." That drug blocks a cellular receptor I haven't heard of that's involved in a cascade of interactions I haven't thought about since medical school. The resulting disruption reduces disease burden, typically at great expense to the medical system, the patient, or both. We've truly entered the era of precision medicine. It's not enough to understand disease; you also must know its heterogeneous expression so that you can prescribe the 'mab that targets the biology responsible for variants in behavior. 2023-07-06

The COVID-19 public health emergency (PHE) certainly affected hospital finances, but government aid may have given some organizations' bottom lines an oversized boost. A new study published in JAMA Health Forum found that many hospitals achieved all-time high financial positions 2 years into the pandemic despite rising supply and labor costs, suggesting that they may have received too much relief funding. 2023-07-19

Federal auditors have found that Medicaid managed care organizations (MCOs) denied, on average, one of every eight prior authorization requests in 2019, echoing recent concerns about similar denials for Medicare patients. 2023-07-27

2023-11-12

Montevideo, 6 December 2023 (PAHO) - The Director of the Pan American Health Organization (PAHO), Dr. Jarbas Barbosa, visited Uruguay this week where he met with senior government officials, legislators and deans of medical schools. The PAHO Director also visited hospitals and health centers and attended the Regional Forum: Alliance for Primary… 2023-12-09